SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions, according to a person familiar with the situation and employee posts on social media.
https://www.statnews.com/2024/10/13/saliogen-therapeutics-layoffs-gene-editing-biotech/